Loading...
Innovative Eyewear, Inc.
LUCYW•NASDAQ
Healthcare
Medical - Instruments & Supplies
$0.06
$0.003(5.09%)

Financial performance has remained strong, with revenue growing from $615754.00 in Q4 2023 to $253599.00 in Q3 2024. Gross profit continued to perform well, with margins at 23% in the latest quarter. Operating income reached -$1.76M in Q3 2024, holding a steady -695% margin. While R&D and SG&A expenses fluctuated, EBITDA remained robust at -$1.69M. Net income dropped to -$1.72B, keeping EPS at -$990.72. With disciplined cost control and operational efficiency, the company supported consistent profitability, reflecting its ability to deliver stable shareholder value.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan